Group One Trading’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-159,700
| Closed | -$8.38M | – | 7353 |
|
|
2020
Q3 | $8.38M | Buy |
159,700
+139,000
| +671% | +$5.75M | 0.03% | 615 |
|
|
2020
Q2 | $689K | Sell |
20,700
-19,300
| -48% | -$615K | ﹤0.01% | 2359 |
|
|
2020
Q1 | $1.09M | Buy |
40,000
+18,700
| +88% | +$521K | 0.01% | 1465 |
|
|
2019
Q4 | $420K | Buy |
21,300
+20,200
| +1,836% | +$323K | ﹤0.01% | 2586 |
|
|
2019
Q3 | $14K | Sell |
1,100
-3,000
| -73% | -$36.2K | ﹤0.01% | 4500 |
|
|
2019
Q2 | $51K | Buy |
+4,100
| New | +$54.4K | ﹤0.01% | 3767 |
|
|
2018
Q4 | – | Sell |
-12,400
| Closed | -$326K | – | 5706 |
|
|
2018
Q3 | $326K | Hold |
12,400
| – | – | ﹤0.01% | 2639 |
|
|
2018
Q2 | $254K | Sell |
12,400
-1,500
| -11% | -$32.2K | ﹤0.01% | 2863 |
|
|
2018
Q1 | $252K | Buy |
13,900
+12,400
| +827% | +$207K | ﹤0.01% | 2602 |
|
|
2017
Q4 | $21K | Buy |
1,500
+500
| +50% | +$6.76K | ﹤0.01% | 4147 |
|
|
2017
Q3 | $19K | Sell |
1,000
-1,600
| -62% | -$26.7K | ﹤0.01% | 4096 |
|
|
2017
Q2 | $44K | Buy |
2,600
+500
| +24% | +$7.61K | ﹤0.01% | 3576 |
|
|
2017
Q1 | $28K | Buy |
+2,100
| New | +$32.9K | ﹤0.01% | 3729 |
|
|
2016
Q4 | – | Sell |
-1,000
| Closed | -$12K | – | 5031 |
|
|
2016
Q3 | $12K | Buy |
1,000
+100
| +11% | +$1.18K | ﹤0.01% | 4001 |
|
|
2016
Q2 | $10K | Buy |
900
+800
| +800% | +$8.25K | ﹤0.01% | 4086 |
|
|
2016
Q1 | $1K | Buy |
+100
| New | +$1.08K | ﹤0.01% | 4469 |
|
|
2015
Q4 | – | Sell |
-700
| Closed | -$11K | – | 5291 |
|
|
2015
Q3 | $11K | Sell |
700
-2,400
| -77% | -$49.1K | ﹤0.01% | 4279 |
|
|
2015
Q2 | $71K | Sell |
3,100
-7,100
| -70% | -$141K | ﹤0.01% | 3322 |
|
|
2015
Q1 | $155K | Sell |
10,200
-11,600
| -53% | -$151K | ﹤0.01% | 2575 |
|
|
2014
Q4 | $262K | Buy |
21,800
+13,200
| +153% | +$151K | ﹤0.01% | 2084 |
|
|
2014
Q3 | $98K | Sell |
8,600
-1,900
| -18% | -$21.7K | ﹤0.01% | 3015 |
|
|
2014
Q2 | $127K | Sell |
10,500
-44,800
| -81% | -$529K | ﹤0.01% | 2775 |
|
|
2014
Q1 | $644K | Buy |
55,300
+24,500
| +80% | +$415K | 0.01% | 1444 |
|
|
2013
Q4 | $545K | Buy |
30,800
+2,900
| +10% | +$48.7K | 0.01% | 1602 |
|
|
2013
Q3 | $401K | Buy |
27,900
+8,000
| +40% | +$122K | 0.01% | 1807 |
|
|
2013
Q2 | $300K | Buy |
+19,900
| New | +$263K | 0.01% | 1795 |
|
Group One Trading's MNTA Position: Q3 2019 in Review
Group One Trading sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2019, closing a stake of 1,200 shares — an estimated $14.5K sold.
Group One Trading first reported a position in MNTA in Q4 2013 and held it in 13 quarters. The position peaked at $369K in Q2 2014. 154 funds tracked by Wall St. Rank hold MNTA as of Q3 2019.
- Group One Trading reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
- Group One Trading sold 1,200 Momenta Pharmaceuticals, Inc. shares in Q3 2019, an estimated $14.5K.
- Group One Trading first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and held it in 13 quarters.
- Group One Trading's Momenta Pharmaceuticals, Inc. position peaked at $369K in Q2 2014.
- 154 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2019.
Based on Group One Trading's 13F filing for Q3 2019, filed 12 Nov 2019.